Citation: Sok Kean Khoo. Biofluid-based Biomarkers for Parkinsons Disease: A New Paradigm[J]. AIMS Medical Science, 2015, 2(4): 371-373. doi: 10.3934/medsci.2015.4.371
[1] | Petillo D, Orey S, Tan AC, et al. (2015) Parkinson's disease-related circulating microRNA biomarkers—a validation study. AIMS Med Sci 2: 7-14. doi: 10.3934/medsci.2015.1.7 |
[2] | Khoo SK, Petillo D, Kang UJ, et al. (2012) Plasma-based circulating microRNA biomarkers for Parkinson's disease. J Parkinson's Dis 2: 321-331. |
[3] | White VJ, Nayak RC (2015) Re-circulating phagocytes loaded with CNS debris: a potential marker of neurodegeneration in Parkinson's disease? AIMS Med Sci 2: 26-34. doi: 10.3934/medsci.2015.1.26 |
[4] | Zucca FA, Segura-Aguilar J, Ferrari E, et al. (2015) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease. Prog Neurobiol. |
[5] | Conti A, Alessio M (2015) Proteomics for cerebrospinal fluid biomarker identification in Parkinson's disease: methods and critical aspects. AIMS Med Sci 2: 1-6. |
[6] | Mollenhauer B, Parnetti L, Rektorova I, et al. (2015) Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders. J Neurochem. |
[7] | Magdalinou NK, Paterson RW, Schott JM, et al. (2015) A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 86: 1240-1247. doi: 10.1136/jnnp-2014-309562 |
[8] | Shinde S, Mukhopadhyay S, Mohsen G, et al. (2015) Biofluid-based microRNA biomarkers for Parkinson's disease: an overview and update. AIMS Med Sci 2: 15-25. doi: 10.3934/medsci.2015.1.15 |
[9] | DeMarshall CA, Sarkar A, Nagele RG (2015) Serum autoantibodies as biomarkers for Parkinson's disease: background and utility. AIMS Med Sci 2: 316-327. doi: 10.3934/medsci.2015.4.316 |